Government

The FDA faces a quandary—increasing oversight of LDTs to protect public health without affecting the quality of patient care

The cuts would have affected approximately 800 clinical laboratory services, cutting reimbursement up to 15 percent

If Congress fails to act before January 1, clinical labs will see almost immediate reductions in reimbursements

A recently introduced bill aims to give health care workers better protection by imposing stiffer penalties on those who would do them harm

The funding will help expand public health lab fellowship programs and add a new public health internship program

The immediate and lingering effects on agencies and people